Key drug of Hungary's Richter subject of temporary EMA measures

Share price drops sharply.

Hungary Richter could cause quite a surprise on Monday

Earnings report expected to show profit contraction.

Hungary Richter drug cariprazine passes Phase III bipolar depression trials

Hungary's Richter reacts to Esmya probe

One of key products under EMA investigation.

European Medicines Agency probes product of Hungary's Richter

Flagship product Emsya under the microscope. Richter reacts.

ANALYST VIEW - Jefferies raises target price for Hungary's Richter

After robust Q3 figures.

Even the rouble cannot ruin the quarter for Hungary's Richter

Profit greatly beats expectations.

Profit of Hungary's Richter seen up despite headwinds

Regardless of rouble trouble.

Hungary Richter keeps piling up own shares

Pharma firm buys treasury shares again for HUF 370 mn.

Hungary Richter buys stake in U.S. company

Signs exclusive distribution agreement with Prima-Temp.

Hungary Richter signs deal with Sweden's Pharmanest

For the commercialisation of novel drug in Europe, Latin America and other markets.

CEO of Hungary's Richter steps down

Erik Bogsch will remain Chairman of the Board, though.

Hungary Richter appoints new director

As of 1 August.

Hungary Richter surprises to the upside again

Despite profit plunge.

Hungary Richter to report profit erosion for Q2 - analysts

Earnings report to be published this week.

Hungary's Richter delivers bombastic news

Marketing of key drug green-lighted for Western Europe.

Fascinating news from Hungary's Richter

Key drug to hit shelves in Western Europe soon.

This how Hungary's Richter will pay dividend this year

Nearly 20 billion forints worth of dividend will be paid.

Hungary Richter raises revenue guidance for 2017

Operating profit margin also seen higher.

Profit soars at Hungary's Richter

Leading pharma reports robust Q1 results.